Search research articles
Contact Us
Filters
Showing results (111-120 of 119) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 119 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 25, 2000
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
T R Spitzer, S McAfee, R Sackstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2011
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
W P Yong, B C Goh, R A Soo, et al.
Bone Marrow Transplantation
|
July 28, 2010
Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
H C Toh, W K Chia, L Sun, et al.
Scientific Reports
|
November 22, 2018
Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women
Lara R Dugas, Beatriz Peñalver Bernabé, Medha Priyadarshini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W M Tai, W P Yong, C Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2016
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W M Tai, W P Yong, C Lim, et al.
Current Cancer Drug Targets
|
September 17, 2009
Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma
H Huynh, V C Ngo, S P Choo, et al.
Cancer Medicine
|
October 9, 2021
Prostate cancer in multi-ethnic Asian men: Real-world experience in the Malaysia Prostate Cancer (M-CaP) Study
Jasmine Lim, Rohan Malek, Sathiyananthan Jr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
H C Toh, M-H Yang, H-M Wang, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 119) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 119 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 25, 2000
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
T R Spitzer, S McAfee, R Sackstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 10, 2011
Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
W P Yong, B C Goh, R A Soo, et al.
Bone Marrow Transplantation
|
July 28, 2010
Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
H C Toh, W K Chia, L Sun, et al.
Scientific Reports
|
November 22, 2018
Decreased microbial co-occurrence network stability and SCFA receptor level correlates with obesity in African-origin women
Lara R Dugas, Beatriz Peñalver Bernabé, Medha Priyadarshini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W M Tai, W P Yong, C Lim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2016
A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)
W M Tai, W P Yong, C Lim, et al.
Current Cancer Drug Targets
|
September 17, 2009
Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma
H Huynh, V C Ngo, S P Choo, et al.
Cancer Medicine
|
October 9, 2021
Prostate cancer in multi-ethnic Asian men: Real-world experience in the Malaysia Prostate Cancer (M-CaP) Study
Jasmine Lim, Rohan Malek, Sathiyananthan Jr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
H C Toh, M-H Yang, H-M Wang, et al.
Page
of 12